查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1867505

合成生物學技術：全球市場佔有率和排名、總收入和需求預測（2025-2031年）

Synthetic Biology Technology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 131 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球合成生物學技術市場預計在 2024 年達到 17.36 億美元，預計到 2031 年將達到 44.47 億美元，在 2025 年至 2031 年的預測期內，複合年成長率將達到 14.0%。

合成生物學是一個跨學科、工程主導的平台，用於重新設計、建構和編程生物系統。它涵蓋基因合成、基因迴路設計、代謝工程、細胞工廠建構以及生物資訊學和自動化技術的整合。透過利用模組化遺傳元件、高通量DNA合成和定序以及機器學習驅動的設計-構建-測試-學習（DBTL）循環，合成生物學將生物體轉化為可程式設計的“生物機器”，用於開發新型療法、精準診斷、永續材料以及農業和能源解決方案。作為支撐生物技術價值鏈上游的基礎技術，合成生物學加速了從實驗室規模實驗到商業性化生物製造的轉變，從而實現策略差異化和長期企業價值創造。

產業界和政府對永續替代方案、精準醫療和生物製造的策略性追求正在加速合成生物學的產業化進程。根據公司揭露，主要企業正將合成生物學定位為長期驅動力，力求透過平台能力、自動化和強化合作夥伴生態系統來提升交付速度和產品廣度。同時，國家層級的工程生物學戰略和公共研究經費正在降低商業化的不確定性，並將資本和產業資源引入該領域。技術進步——例如降低DNA合成和高通量篩檢的成本，以及將人工智慧和自動化技術融入DBTL（設計、開發、轉換）週期——正在縮短從概念到可擴展商業化的流程，為執行長、行銷人員和投資者帶來清晰的策略價值和潛在收益。合成生物學的商業化面臨著監管、倫理和生物安全的挑戰。生物數據和樣本跨境管理的不一致性、不斷變化的基因編輯法規以及高風險生物工作的社會敏感性，都要求加強對合規性和透明度的投入。平台策略也造成了技術和資金壁壘，使得規模較小的創新者難以擴大規模並進入市場。此外，投資者和董事會在製定策略性舉措時必須認真考慮規模化生產、環境和倫理爭議以及系統性風險等方面的不確定性。終端市場正從購買單一技術轉向基於平台的客製化服務。製藥公司和合約研究組織 (CRO) 傾向於與能夠提供端到端設計到製造 (DBTL) 和可擴展生產的供應商建立深度合作關係，從而縮短臨床試驗夥伴關係。同時，農業、材料和能源產業正在尋求生物製造替代化石原料的方案，並高度重視具有成熟規模化生產能力的平台。此外，市場對檢驗的合規性、產品可追溯性和供應鏈韌性的需求也在不斷成長，這使得能夠整合「技術+製造+合規」能力的供應商在贏得大客戶和長期合約方面更具優勢。

本報告旨在按地區/國家、類型和應用對全球合成生物學技術市場進行全面分析，重點關注總收入、市場佔有率和主要企業的排名。

本報告以銷售收入為基準年（2024年），對合成生物學技術市場規模、估算和預測進行了呈現，並包含了2020年至2031年的歷史數據和預測數據。報告運用定量和定性分析，幫助讀者制定業務/成長策略，評估市場競爭格局，分析公司在當前市場中的地位，並就合成生物學技術做出明智的商業決策。

市場區隔

公司

  • Genescript
  • Thermo Fisher Scientific
  • IDT
  • Eurofins Genomics
  • DNA 2.0（ATUM）
  • BBI
  • Azenta Life Sciences
  • SBS Genetech
  • Bio Basic
  • Twist Bioscience
  • OriGene
  • Bioneer
  • Eton Bioscience
  • Synbio Technologies
  • Eurogentec
  • Ginkgo Bioworks
  • Agilent

按類型分類的細分市場

  • 基因合成
  • 寡核苷酸合成
  • 生物資訊分析
  • DNA組裝

應用領域

  • 製藥
  • 工業
  • 農業
  • 其他

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Synthetic Biology Technology was estimated to be worth US$ 1736 million in 2024 and is forecast to a readjusted size of US$ 4447 million by 2031 with a CAGR of 14.0% during the forecast period 2025-2031.

Synthetic Biology Technology is an interdisciplinary engineering-driven platform that redesigns, constructs, and programs biological systems. It spans gene synthesis, genetic circuit design, metabolic engineering, the construction of cellular factories, and the integration of bioinformatics with automation. Using modular genetic parts, high-throughput DNA synthesis and sequencing, and machine-learning-guided design-build-test-learn (DBTL) cycles, synthetic biology transforms organisms into programmable "biological machines" for novel therapeutics, precision diagnostics, sustainable materials, and agricultural or energy solutions. As an upstream enabler of the biotech value chain, synthetic biology accelerates the shift from lab-scale experiments to commercial biological manufacturing, creating strategic differentiation and long-term enterprise value.

The strategic pursuit of sustainable alternatives, precision medicines, and biological manufacturing by industry and governments is accelerating the industrialization of synthetic biology. Corporate filings show that leading companies are positioning synthetic biology as a long-term growth driver, enhancing platform capabilities, automation, and partner ecosystems to increase delivery speed and product breadth; meanwhile, national engineering biology strategies and public research funding reduce commercialization uncertainty and channel capital and industry resources into the field. Technological advances-lowering costs in DNA synthesis and high-throughput screening and embedding AI and automation into the DBTL cycle-shorten the pathway from concept to scalable product, offering visible strategic value and profit potential to CEOs, marketers, and investors.Commercial deployment of synthetic biology faces regulatory, ethical, and biosafety challenges: inconsistent cross-border governance of biological data and samples, evolving gene-editing regulations, and the social sensitivity of high-risk biological work demand greater investments in compliance and transparency. Platform strategies also create technical and capital barriers, making scale-up and market entry difficult for smaller innovators. Moreover, scale-up uncertainties, environmental and ethical controversies, and systemic risks must be weighed by investors and boards when shaping strategic initiatives. End markets are shifting from single-point technology purchases toward platformized, customized services: pharma companies and CROs prefer deep partnerships with providers that offer end-to-end DBTL and scalable manufacturing to compress timelines to clinic; agriculture, materials, and energy sectors seek bio-manufactured alternatives to fossil feedstocks and favor platforms with proven scale-up performance. Concurrently, demand is rising for verifiable compliance, product traceability, and supply-chain resilience-advantages that integrated "technology + manufacturing + compliance" vendors can leverage to win large customers and long-term contracts.

This report aims to provide a comprehensive presentation of the global market for Synthetic Biology Technology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Synthetic Biology Technology by region & country, by Type, and by Application.

The Synthetic Biology Technology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Synthetic Biology Technology.

Market Segmentation

By Company

  • Genescript
  • Thermo Fisher Scientific
  • IDT
  • Eurofins Genomics
  • DNA 2.0 (ATUM)
  • BBI
  • Azenta Life Sciences
  • SBS Genetech
  • Bio Basic
  • Twist Bioscience
  • OriGene
  • Bioneer
  • Eton Bioscience
  • Synbio Technologies
  • Eurogentec
  • Ginkgo Bioworks
  • Agilent

Segment by Type

  • Gene Synthesis
  • Oligonucleotide Synthesis
  • Bioinformatics Analysis
  • DNA Assembly

Segment by Application

  • Medicine
  • Chemical Industry
  • Agriculture
  • Other

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Synthetic Biology Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Synthetic Biology Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Synthetic Biology Technology in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Synthetic Biology Technology Product Introduction
  • 1.2 Global Synthetic Biology Technology Market Size Forecast (2020-2031)
  • 1.3 Synthetic Biology Technology Market Trends & Drivers
    • 1.3.1 Synthetic Biology Technology Industry Trends
    • 1.3.2 Synthetic Biology Technology Market Drivers & Opportunity
    • 1.3.3 Synthetic Biology Technology Market Challenges
    • 1.3.4 Synthetic Biology Technology Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Synthetic Biology Technology Players Revenue Ranking (2024)
  • 2.2 Global Synthetic Biology Technology Revenue by Company (2020-2025)
  • 2.3 Key Companies Synthetic Biology Technology Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Synthetic Biology Technology Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Synthetic Biology Technology
  • 2.6 Synthetic Biology Technology Market Competitive Analysis
    • 2.6.1 Synthetic Biology Technology Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Synthetic Biology Technology Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Biology Technology as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Gene Synthesis
    • 3.1.2 Oligonucleotide Synthesis
    • 3.1.3 Bioinformatics Analysis
    • 3.1.4 DNA Assembly
  • 3.2 Global Synthetic Biology Technology Sales Value by Type
    • 3.2.1 Global Synthetic Biology Technology Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Synthetic Biology Technology Sales Value, by Type (2020-2031)
    • 3.2.3 Global Synthetic Biology Technology Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Medicine
    • 4.1.2 Chemical Industry
    • 4.1.3 Agriculture
    • 4.1.4 Other
  • 4.2 Global Synthetic Biology Technology Sales Value by Application
    • 4.2.1 Global Synthetic Biology Technology Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Synthetic Biology Technology Sales Value, by Application (2020-2031)
    • 4.2.3 Global Synthetic Biology Technology Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Synthetic Biology Technology Sales Value by Region
    • 5.1.1 Global Synthetic Biology Technology Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Synthetic Biology Technology Sales Value by Region (2020-2025)
    • 5.1.3 Global Synthetic Biology Technology Sales Value by Region (2026-2031)
    • 5.1.4 Global Synthetic Biology Technology Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Synthetic Biology Technology Sales Value, 2020-2031
    • 5.2.2 North America Synthetic Biology Technology Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Synthetic Biology Technology Sales Value, 2020-2031
    • 5.3.2 Europe Synthetic Biology Technology Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Synthetic Biology Technology Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Synthetic Biology Technology Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Synthetic Biology Technology Sales Value, 2020-2031
    • 5.5.2 South America Synthetic Biology Technology Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Synthetic Biology Technology Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Synthetic Biology Technology Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Synthetic Biology Technology Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Synthetic Biology Technology Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Synthetic Biology Technology Sales Value, 2020-2031
    • 6.3.2 United States Synthetic Biology Technology Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Synthetic Biology Technology Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Synthetic Biology Technology Sales Value, 2020-2031
    • 6.4.2 Europe Synthetic Biology Technology Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Synthetic Biology Technology Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Synthetic Biology Technology Sales Value, 2020-2031
    • 6.5.2 China Synthetic Biology Technology Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Synthetic Biology Technology Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Synthetic Biology Technology Sales Value, 2020-2031
    • 6.6.2 Japan Synthetic Biology Technology Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Synthetic Biology Technology Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Synthetic Biology Technology Sales Value, 2020-2031
    • 6.7.2 South Korea Synthetic Biology Technology Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Synthetic Biology Technology Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Synthetic Biology Technology Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Synthetic Biology Technology Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Synthetic Biology Technology Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Synthetic Biology Technology Sales Value, 2020-2031
    • 6.9.2 India Synthetic Biology Technology Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Synthetic Biology Technology Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Genescript
    • 7.1.1 Genescript Profile
    • 7.1.2 Genescript Main Business
    • 7.1.3 Genescript Synthetic Biology Technology Products, Services and Solutions
    • 7.1.4 Genescript Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Genescript Recent Developments
  • 7.2 Thermo Fisher Scientific
    • 7.2.1 Thermo Fisher Scientific Profile
    • 7.2.2 Thermo Fisher Scientific Main Business
    • 7.2.3 Thermo Fisher Scientific Synthetic Biology Technology Products, Services and Solutions
    • 7.2.4 Thermo Fisher Scientific Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Thermo Fisher Scientific Recent Developments
  • 7.3 IDT
    • 7.3.1 IDT Profile
    • 7.3.2 IDT Main Business
    • 7.3.3 IDT Synthetic Biology Technology Products, Services and Solutions
    • 7.3.4 IDT Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
    • 7.3.5 IDT Recent Developments
  • 7.4 Eurofins Genomics
    • 7.4.1 Eurofins Genomics Profile
    • 7.4.2 Eurofins Genomics Main Business
    • 7.4.3 Eurofins Genomics Synthetic Biology Technology Products, Services and Solutions
    • 7.4.4 Eurofins Genomics Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Eurofins Genomics Recent Developments
  • 7.5 DNA 2.0 (ATUM)
    • 7.5.1 DNA 2.0 (ATUM) Profile
    • 7.5.2 DNA 2.0 (ATUM) Main Business
    • 7.5.3 DNA 2.0 (ATUM) Synthetic Biology Technology Products, Services and Solutions
    • 7.5.4 DNA 2.0 (ATUM) Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
    • 7.5.5 DNA 2.0 (ATUM) Recent Developments
  • 7.6 BBI
    • 7.6.1 BBI Profile
    • 7.6.2 BBI Main Business
    • 7.6.3 BBI Synthetic Biology Technology Products, Services and Solutions
    • 7.6.4 BBI Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
    • 7.6.5 BBI Recent Developments
  • 7.7 Azenta Life Sciences
    • 7.7.1 Azenta Life Sciences Profile
    • 7.7.2 Azenta Life Sciences Main Business
    • 7.7.3 Azenta Life Sciences Synthetic Biology Technology Products, Services and Solutions
    • 7.7.4 Azenta Life Sciences Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Azenta Life Sciences Recent Developments
  • 7.8 SBS Genetech
    • 7.8.1 SBS Genetech Profile
    • 7.8.2 SBS Genetech Main Business
    • 7.8.3 SBS Genetech Synthetic Biology Technology Products, Services and Solutions
    • 7.8.4 SBS Genetech Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
    • 7.8.5 SBS Genetech Recent Developments
  • 7.9 Bio Basic
    • 7.9.1 Bio Basic Profile
    • 7.9.2 Bio Basic Main Business
    • 7.9.3 Bio Basic Synthetic Biology Technology Products, Services and Solutions
    • 7.9.4 Bio Basic Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Bio Basic Recent Developments
  • 7.10 Twist Bioscience
    • 7.10.1 Twist Bioscience Profile
    • 7.10.2 Twist Bioscience Main Business
    • 7.10.3 Twist Bioscience Synthetic Biology Technology Products, Services and Solutions
    • 7.10.4 Twist Bioscience Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Twist Bioscience Recent Developments
  • 7.11 OriGene
    • 7.11.1 OriGene Profile
    • 7.11.2 OriGene Main Business
    • 7.11.3 OriGene Synthetic Biology Technology Products, Services and Solutions
    • 7.11.4 OriGene Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
    • 7.11.5 OriGene Recent Developments
  • 7.12 Bioneer
    • 7.12.1 Bioneer Profile
    • 7.12.2 Bioneer Main Business
    • 7.12.3 Bioneer Synthetic Biology Technology Products, Services and Solutions
    • 7.12.4 Bioneer Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Bioneer Recent Developments
  • 7.13 Eton Bioscience
    • 7.13.1 Eton Bioscience Profile
    • 7.13.2 Eton Bioscience Main Business
    • 7.13.3 Eton Bioscience Synthetic Biology Technology Products, Services and Solutions
    • 7.13.4 Eton Bioscience Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
    • 7.13.5 Eton Bioscience Recent Developments
  • 7.14 Synbio Technologies
    • 7.14.1 Synbio Technologies Profile
    • 7.14.2 Synbio Technologies Main Business
    • 7.14.3 Synbio Technologies Synthetic Biology Technology Products, Services and Solutions
    • 7.14.4 Synbio Technologies Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
    • 7.14.5 Synbio Technologies Recent Developments
  • 7.15 Eurogentec
    • 7.15.1 Eurogentec Profile
    • 7.15.2 Eurogentec Main Business
    • 7.15.3 Eurogentec Synthetic Biology Technology Products, Services and Solutions
    • 7.15.4 Eurogentec Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
    • 7.15.5 Eurogentec Recent Developments
  • 7.16 Ginkgo Bioworks
    • 7.16.1 Ginkgo Bioworks Profile
    • 7.16.2 Ginkgo Bioworks Main Business
    • 7.16.3 Ginkgo Bioworks Synthetic Biology Technology Products, Services and Solutions
    • 7.16.4 Ginkgo Bioworks Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
    • 7.16.5 Ginkgo Bioworks Recent Developments
  • 7.17 Agilent
    • 7.17.1 Agilent Profile
    • 7.17.2 Agilent Main Business
    • 7.17.3 Agilent Synthetic Biology Technology Products, Services and Solutions
    • 7.17.4 Agilent Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
    • 7.17.5 Agilent Recent Developments

8 Industry Chain Analysis

  • 8.1 Synthetic Biology Technology Industrial Chain
  • 8.2 Synthetic Biology Technology Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Synthetic Biology Technology Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Synthetic Biology Technology Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Synthetic Biology Technology Market Trends
  • Table 2. Synthetic Biology Technology Market Drivers & Opportunity
  • Table 3. Synthetic Biology Technology Market Challenges
  • Table 4. Synthetic Biology Technology Market Restraints
  • Table 5. Global Synthetic Biology Technology Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Synthetic Biology Technology Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Synthetic Biology Technology Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Synthetic Biology Technology Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Synthetic Biology Technology
  • Table 10. Global Synthetic Biology Technology Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Biology Technology as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Synthetic Biology Technology Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Synthetic Biology Technology Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Synthetic Biology Technology Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Synthetic Biology Technology Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Synthetic Biology Technology Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Synthetic Biology Technology Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Synthetic Biology Technology Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Synthetic Biology Technology Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Synthetic Biology Technology Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Synthetic Biology Technology Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Synthetic Biology Technology Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Synthetic Biology Technology Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Synthetic Biology Technology Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Synthetic Biology Technology Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Synthetic Biology Technology Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Synthetic Biology Technology Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Synthetic Biology Technology Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Synthetic Biology Technology Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Genescript Basic Information List
  • Table 32. Genescript Description and Business Overview
  • Table 33. Genescript Synthetic Biology Technology Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Synthetic Biology Technology Business of Genescript (2020-2025)
  • Table 35. Genescript Recent Developments
  • Table 36. Thermo Fisher Scientific Basic Information List
  • Table 37. Thermo Fisher Scientific Description and Business Overview
  • Table 38. Thermo Fisher Scientific Synthetic Biology Technology Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Synthetic Biology Technology Business of Thermo Fisher Scientific (2020-2025)
  • Table 40. Thermo Fisher Scientific Recent Developments
  • Table 41. IDT Basic Information List
  • Table 42. IDT Description and Business Overview
  • Table 43. IDT Synthetic Biology Technology Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Synthetic Biology Technology Business of IDT (2020-2025)
  • Table 45. IDT Recent Developments
  • Table 46. Eurofins Genomics Basic Information List
  • Table 47. Eurofins Genomics Description and Business Overview
  • Table 48. Eurofins Genomics Synthetic Biology Technology Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Synthetic Biology Technology Business of Eurofins Genomics (2020-2025)
  • Table 50. Eurofins Genomics Recent Developments
  • Table 51. DNA 2.0 (ATUM) Basic Information List
  • Table 52. DNA 2.0 (ATUM) Description and Business Overview
  • Table 53. DNA 2.0 (ATUM) Synthetic Biology Technology Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Synthetic Biology Technology Business of DNA 2.0 (ATUM) (2020-2025)
  • Table 55. DNA 2.0 (ATUM) Recent Developments
  • Table 56. BBI Basic Information List
  • Table 57. BBI Description and Business Overview
  • Table 58. BBI Synthetic Biology Technology Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Synthetic Biology Technology Business of BBI (2020-2025)
  • Table 60. BBI Recent Developments
  • Table 61. Azenta Life Sciences Basic Information List
  • Table 62. Azenta Life Sciences Description and Business Overview
  • Table 63. Azenta Life Sciences Synthetic Biology Technology Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Synthetic Biology Technology Business of Azenta Life Sciences (2020-2025)
  • Table 65. Azenta Life Sciences Recent Developments
  • Table 66. SBS Genetech Basic Information List
  • Table 67. SBS Genetech Description and Business Overview
  • Table 68. SBS Genetech Synthetic Biology Technology Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Synthetic Biology Technology Business of SBS Genetech (2020-2025)
  • Table 70. SBS Genetech Recent Developments
  • Table 71. Bio Basic Basic Information List
  • Table 72. Bio Basic Description and Business Overview
  • Table 73. Bio Basic Synthetic Biology Technology Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Synthetic Biology Technology Business of Bio Basic (2020-2025)
  • Table 75. Bio Basic Recent Developments
  • Table 76. Twist Bioscience Basic Information List
  • Table 77. Twist Bioscience Description and Business Overview
  • Table 78. Twist Bioscience Synthetic Biology Technology Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Synthetic Biology Technology Business of Twist Bioscience (2020-2025)
  • Table 80. Twist Bioscience Recent Developments
  • Table 81. OriGene Basic Information List
  • Table 82. OriGene Description and Business Overview
  • Table 83. OriGene Synthetic Biology Technology Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Synthetic Biology Technology Business of OriGene (2020-2025)
  • Table 85. OriGene Recent Developments
  • Table 86. Bioneer Basic Information List
  • Table 87. Bioneer Description and Business Overview
  • Table 88. Bioneer Synthetic Biology Technology Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Synthetic Biology Technology Business of Bioneer (2020-2025)
  • Table 90. Bioneer Recent Developments
  • Table 91. Eton Bioscience Basic Information List
  • Table 92. Eton Bioscience Description and Business Overview
  • Table 93. Eton Bioscience Synthetic Biology Technology Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Synthetic Biology Technology Business of Eton Bioscience (2020-2025)
  • Table 95. Eton Bioscience Recent Developments
  • Table 96. Synbio Technologies Basic Information List
  • Table 97. Synbio Technologies Description and Business Overview
  • Table 98. Synbio Technologies Synthetic Biology Technology Products, Services and Solutions
  • Table 99. Revenue (US$ Million) in Synthetic Biology Technology Business of Synbio Technologies (2020-2025)
  • Table 100. Synbio Technologies Recent Developments
  • Table 101. Eurogentec Basic Information List
  • Table 102. Eurogentec Description and Business Overview
  • Table 103. Eurogentec Synthetic Biology Technology Products, Services and Solutions
  • Table 104. Revenue (US$ Million) in Synthetic Biology Technology Business of Eurogentec (2020-2025)
  • Table 105. Eurogentec Recent Developments
  • Table 106. Ginkgo Bioworks Basic Information List
  • Table 107. Ginkgo Bioworks Description and Business Overview
  • Table 108. Ginkgo Bioworks Synthetic Biology Technology Products, Services and Solutions
  • Table 109. Revenue (US$ Million) in Synthetic Biology Technology Business of Ginkgo Bioworks (2020-2025)
  • Table 110. Ginkgo Bioworks Recent Developments
  • Table 111. Agilent Basic Information List
  • Table 112. Agilent Description and Business Overview
  • Table 113. Agilent Synthetic Biology Technology Products, Services and Solutions
  • Table 114. Revenue (US$ Million) in Synthetic Biology Technology Business of Agilent (2020-2025)
  • Table 115. Agilent Recent Developments
  • Table 116. Key Raw Materials Lists
  • Table 117. Raw Materials Key Suppliers Lists
  • Table 118. Synthetic Biology Technology Downstream Customers
  • Table 119. Synthetic Biology Technology Distributors List
  • Table 120. Research Programs/Design for This Report
  • Table 121. Key Data Information from Secondary Sources
  • Table 122. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Synthetic Biology Technology Product Picture
  • Figure 2. Global Synthetic Biology Technology Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Synthetic Biology Technology Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Synthetic Biology Technology Report Years Considered
  • Figure 5. Global Synthetic Biology Technology Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Synthetic Biology Technology Revenue in 2024
  • Figure 7. Synthetic Biology Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Gene Synthesis Picture
  • Figure 9. Oligonucleotide Synthesis Picture
  • Figure 10. Bioinformatics Analysis Picture
  • Figure 11. DNA Assembly Picture
  • Figure 12. Global Synthetic Biology Technology Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 13. Global Synthetic Biology Technology Sales Value Market Share by Type, 2024 & 2031
  • Figure 14. Product Picture of Medicine
  • Figure 15. Product Picture of Chemical Industry
  • Figure 16. Product Picture of Agriculture
  • Figure 17. Product Picture of Other
  • Figure 18. Global Synthetic Biology Technology Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 19. Global Synthetic Biology Technology Sales Value Market Share by Application, 2024 & 2031
  • Figure 20. North America Synthetic Biology Technology Sales Value (2020-2031) & (US$ Million)
  • Figure 21. North America Synthetic Biology Technology Sales Value by Country (%), 2024 VS 2031
  • Figure 22. Europe Synthetic Biology Technology Sales Value, (2020-2031) & (US$ Million)
  • Figure 23. Europe Synthetic Biology Technology Sales Value by Country (%), 2024 VS 2031
  • Figure 24. Asia Pacific Synthetic Biology Technology Sales Value, (2020-2031) & (US$ Million)
  • Figure 25. Asia Pacific Synthetic Biology Technology Sales Value by Region (%), 2024 VS 2031
  • Figure 26. South America Synthetic Biology Technology Sales Value, (2020-2031) & (US$ Million)
  • Figure 27. South America Synthetic Biology Technology Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Middle East & Africa Synthetic Biology Technology Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Middle East & Africa Synthetic Biology Technology Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Key Countries/Regions Synthetic Biology Technology Sales Value (%), (2020-2031)
  • Figure 31. United States Synthetic Biology Technology Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. United States Synthetic Biology Technology Sales Value by Type (%), 2024 VS 2031
  • Figure 33. United States Synthetic Biology Technology Sales Value by Application (%), 2024 VS 2031
  • Figure 34. Europe Synthetic Biology Technology Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Europe Synthetic Biology Technology Sales Value by Type (%), 2024 VS 2031
  • Figure 36. Europe Synthetic Biology Technology Sales Value by Application (%), 2024 VS 2031
  • Figure 37. China Synthetic Biology Technology Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. China Synthetic Biology Technology Sales Value by Type (%), 2024 VS 2031
  • Figure 39. China Synthetic Biology Technology Sales Value by Application (%), 2024 VS 2031
  • Figure 40. Japan Synthetic Biology Technology Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. Japan Synthetic Biology Technology Sales Value by Type (%), 2024 VS 2031
  • Figure 42. Japan Synthetic Biology Technology Sales Value by Application (%), 2024 VS 2031
  • Figure 43. South Korea Synthetic Biology Technology Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. South Korea Synthetic Biology Technology Sales Value by Type (%), 2024 VS 2031
  • Figure 45. South Korea Synthetic Biology Technology Sales Value by Application (%), 2024 VS 2031
  • Figure 46. Southeast Asia Synthetic Biology Technology Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. Southeast Asia Synthetic Biology Technology Sales Value by Type (%), 2024 VS 2031
  • Figure 48. Southeast Asia Synthetic Biology Technology Sales Value by Application (%), 2024 VS 2031
  • Figure 49. India Synthetic Biology Technology Sales Value, (2020-2031) & (US$ Million)
  • Figure 50. India Synthetic Biology Technology Sales Value by Type (%), 2024 VS 2031
  • Figure 51. India Synthetic Biology Technology Sales Value by Application (%), 2024 VS 2031
  • Figure 52. Synthetic Biology Technology Industrial Chain
  • Figure 53. Synthetic Biology Technology Manufacturing Cost Structure
  • Figure 54. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 55. Bottom-up and Top-down Approaches for This Report
  • Figure 56. Data Triangulation
  • Figure 57. Key Executives Interviewed